The Medigen Vaccine Biologics Corporation (MVC; ) is a pharmaceutical company headquartered in Neihu, Taipei, Taiwan.
The company was founded in October 2012. During the COVID-19 pandemic in Taiwan, the company produces the MVC COVID-19 vaccine to fight the virus.
On 18 March 2026, Vietnam's Ministry of Health has approved the rollout of the Medigen enterovirus vaccine in Vietnam, which is the company's first overseas rollout.
The company has a manufacturing plant in Hsinchu Biomedical Science Park, Zhubei City, Hsinchu County.